Chemical Dependency and Smoking Cessation: Patient's Views - 1

This study has been completed.
Sponsor:
Information provided by:
National Institute on Drug Abuse (NIDA)
ClinicalTrials.gov Identifier:
NCT00051883
First received: January 17, 2003
Last updated: December 22, 2008
Last verified: December 2008
  Purpose

The purpose of this study is to asses patient views on smoking cessation and tobacco harm reduction during drug treatment.


Condition Phase
Tobacco Use Disorder
Phase 4

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Chemical Dependency and Smoking Cessation: Patient's Views

Resource links provided by NLM:


Further study details as provided by National Institute on Drug Abuse (NIDA):

Enrollment: 125
Study Start Date: December 1999
Study Completion Date: February 2005
Detailed Description:

Participants included 34 patients who had never voluntarily quit smoking for longer than 24 hours (continuous smokers), 34 smokers who had quit smoking for at least 24 hours before but had relapsed (relapsers), and 10 former smokers who had been abstinent for at least the past 6 months (successful quitters). We held 7 focus groups, 3 with continuous smokers and 4 with relapsers. Focus groups lasted 2 hours and were held at participants' clinics to preserve confidentiality. We conducted hour-long individual interviews with successful quitters. All participants completed a brief written survey immediately before their session. Survey items included questions on demographics, smoking behaviors, and motivation for cessation, reduction, and nicotine maintenance. We reimbursed all participants $40 and provided a meal to focus group attendees.

  Eligibility

Ages Eligible for Study:   18 Years to 70 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

Substance abuse treatment patients

Criteria

Inclusion Criteria:

Selection criteria included being 18 years or older, smoking 5 or more cigarettes per day for at least 2 years, and being enrolled continuously in methadone maintenance treatment (MMT) for at least the past 2 years.

Exclusion Criteria:

Being less than 18 years of age, smoking 4 or fewer cigarettes per day, smoking less than daily for less than 2 years, and not being enrolled continuously in methadone treatment for at least the 2 past years.

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00051883

Locations
United States, Kansas
University of Kansas Medical Center
Kansas City, Kansas, United States, 66160 7420
Sponsors and Collaborators
Investigators
Principal Investigator: Kimber Richter, Ph.D. University of Kansas
  More Information

No publications provided

Responsible Party: Kimber Richter, PhD, University of Kansas Medical Center
ClinicalTrials.gov Identifier: NCT00051883     History of Changes
Other Study ID Numbers: NIDA-00450-1, K01-00450-1
Study First Received: January 17, 2003
Last Updated: December 22, 2008
Health Authority: United States: Federal Government

Additional relevant MeSH terms:
Tobacco Use Disorder
Chemically-Induced Disorders
Mental Disorders
Substance-Related Disorders

ClinicalTrials.gov processed this record on October 21, 2014